Analysis of the availability and accessibility of hypotensive drugs recommended for use in pregnant women
Author Affiliations1Smolensk State Medical Academy of Minzdrav of Russia, 214004, Smolensk, Nikolaev str., 19–68
2Smolensk State Medical Academy of Minzdrav of Russia, 214004, Smolensk, Nikolaev str., 19–68
Abstract
Aim: To verify the availability and accessibility of hypotensive drugs recommended for use in pregnant women. Materials and methods. The analytical study of normative documents and State Registers of drugs in Russia, the US and the EU has been carried out. Results. It has been established that for the treatment of pregnant women with hypertension of mild and moderate severity it is advisable to use a fairly represented on the Russian market and available: agonists A2 adrenoreceptor-methyldopa (Dopegita); beta-blockers, selective (bisoprolol, metoprolol); blockers slow calcium channels – nifedipine, verapamil.
Key words
References1. Varpakhovskaya I. Cardiovascular drugs on the world and Russian markets (part I) // Remedium. 2000. (10). 74–80. (in Russian)
2. Guskov V. Century the Condition and the forecast of the pharmaceutical market of Kazakhstan / BTA Analytics [Electronic resource]. 2008. leasing.bta.kz/files/9-farma_main.pdf. 15.05.2010. (in Russian)
3. Karpov Yu.A. New guidelines on arterial hypertension RMOAG/GFCF 2010: questions combination therapy // Russkiy meditsinskiy zhurnal. Kardiologiya. 2010. (22). 1290–1297. (in Russian)
4. Markelov M.Yu. Marketing analysis of the market of hypotensive drugs//Information technologies in medical and educational research: Materials of inter-regional scientifically-practical conference. Kursk, 2008. (Pt. 2). 26–27. (in Russian)
5. Morozova T.E., Andrusyshyna T.B., Osorova S.D. Individualized choice of antihypertensive drugs in the metabolic syndrome: effects on adipokines, markers of endothelial dysfunction and systemic inflammation // Lechashchiy vrach. 2011. (2). 11–15. (in Russian)
6. National recommendations of All-Russian scientific society of cardiologists http://www.cardiocity.ru/konferentsii-rekomendatsii/natsionalnye-rekomendatsii-vnok-vserossijskogo-nauchnogo-obschestva-kardiologov. (in Russian)
7. Order of the Ministry of health of the Russian Federation № 918n from 15 November 2012 "On approval of medical aid to patients with cardiovascular diseases". (in Russian)
8. Hoseva E.N., Morozova T.E., Ermakov D.A., Osorova S.D. Problems of safety control of drug therapy in a wide clinical practice: attitudes of patients and health professionals/ Physician-graduate student. 2013. So 57. No 2.1. C. 203–212. (in Russian)
9. Chobanian A.V., Bakris G.L., Black H.R. et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report // JAMA. 2003. 289. 2560–2572.
10. Regitz-Zagrosek V., Blomstrom Lundqvist C., Borghi C. et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) // Eur. Heart J. 2011. 32. (24). 3147–3197.
About Authors (Correspondence):
Konyshko N.A. – candidate of medical sciences, assistant professor of the faculty therapy chair, e-mail: Nkonyshko@yandex.ru
Krikova A.V. – doctor of medical sciences, assistant professor of the pharmacy management and economic chair, е-mail: anna.krikova@mail.ru
Full Text
